Home › Osteosarcoma › Georgia
Osteosarcoma clinical trials in Georgia
10 studies for Osteosarcoma are looking for participants at sites in Georgia.
Cities in Georgia
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
RecruitingPhase 2
Ages 12 to 39 · All sexes · Updated Sep 29, 2026 · NCT04616560Losartan + Sunitinib in Treatment of Osteosarcoma
- Children's Hospital of Atlanta, Atlanta
RecruitingPhase 1
Ages 10 and older · All sexes · Updated Sep 1, 2026 · NCT03900793Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
- Chilldren's Healthcare of Atlanta, Atlanta
RecruitingPhase 1
Up to age 50 · All sexes · Updated Jun 2, 2026 · NCT06492954Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
- Arthur M. Blank Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 1
Ages 1 to 30 · All sexes · Updated Jun 2, 2026 · NCT07144254Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Children's Healthcare of Atlanta - Egleston, Atlanta
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
- Children's Healthcare of Atlanta, Atlanta
RecruitingPhase 1
12 Months · All sexes · Updated Dec 26, 2025 · NCT05400603From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.